N -Myristoyltransferase Inhibitors as a Potential Starting Point for the Development of Antischistosomal Agents

Read full text Summarise with VIRAT
Authors: Mareike Riedel, Collin Zimmer, Cécile Häberli, Jennifer Keiser, Christian Kersten
Cited by: 0
References: 46

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

High Resolution Image Download MS PowerPoint Slide Schistosomiasis remains a major global health challenge, and the threat of emerging praziquantel resistance highlights the need for new therapeutic strategies. Here, the Schistosoma mansoni N -myristoyltransferase was evaluated as a potential drug target. Six reported NMT inhibitors were tested for Sm NMT inhibition and binding, with two compounds showing low nanomolar potency. These also inhibited NMT of S. hematobium and S. japonicum, and exhibit favorable drug-like physicochemical properties. In addition, antiparasitic activity against newly transformed schistosomula and adult worms was investigated. The results confirm NMT as a viable target for drug discovery against schistosomiasis and provide a basis for further optimizations of Sm NMT inhibitors.

Fields of Study & Subjects

Parasites and Host Interactions Trypanosoma species research and implications Helminth infection and control

Publication details

Journal / source
ACS Medicinal Chemistry Letters
Volume
17
Issue
4
Pages
945–951
Publication date
30 March 2026
Language
EN